nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—CYP2D6—Bicalutamide—prostate cancer	0.111	0.505	CbGbCtD
Hydroxychloroquine—CYP2D6—Abiraterone—prostate cancer	0.0921	0.418	CbGbCtD
Hydroxychloroquine—CYP2D6—Doxorubicin—prostate cancer	0.017	0.0773	CbGbCtD
Hydroxychloroquine—TLR7—prostate gland—prostate cancer	0.00899	0.442	CbGeAlD
Hydroxychloroquine—TLR7—testis—prostate cancer	0.00396	0.195	CbGeAlD
Hydroxychloroquine—CYP2D6—urine—prostate cancer	0.00321	0.158	CbGeAlD
Hydroxychloroquine—TLR7—lymph node—prostate cancer	0.00287	0.141	CbGeAlD
Hydroxychloroquine—Chloroquine—GSTA2—prostate cancer	0.00286	0.205	CrCbGaD
Hydroxychloroquine—Primaquine—CYP1B1—prostate cancer	0.00221	0.158	CrCbGaD
Hydroxychloroquine—Amodiaquine—CYP1B1—prostate cancer	0.00188	0.135	CrCbGaD
Hydroxychloroquine—Quinacrine—CYP3A5—prostate cancer	0.00122	0.0875	CrCbGaD
Hydroxychloroquine—Primaquine—CYP1A1—prostate cancer	0.00119	0.0856	CrCbGaD
Hydroxychloroquine—Chloroquine—CYP3A5—prostate cancer	0.00108	0.0776	CrCbGaD
Hydroxychloroquine—Amodiaquine—CYP1A1—prostate cancer	0.00101	0.0727	CrCbGaD
Hydroxychloroquine—CYP2D6—renal system—prostate cancer	0.000786	0.0387	CbGeAlD
Hydroxychloroquine—Primaquine—CYP3A4—prostate cancer	0.000761	0.0546	CrCbGaD
Hydroxychloroquine—Chloroquine—CYP1A1—prostate cancer	0.000733	0.0526	CrCbGaD
Hydroxychloroquine—Quinacrine—CYP3A4—prostate cancer	0.000528	0.0379	CrCbGaD
Hydroxychloroquine—CYP2D6—testis—prostate cancer	0.000508	0.025	CbGeAlD
Hydroxychloroquine—Chloroquine—CYP3A4—prostate cancer	0.000468	0.0336	CrCbGaD
Hydroxychloroquine—Rash—Conjugated Estrogens—prostate cancer	0.000237	0.000544	CcSEcCtD
Hydroxychloroquine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000237	0.000543	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Prednisone—prostate cancer	0.000236	0.000542	CcSEcCtD
Hydroxychloroquine—Headache—Conjugated Estrogens—prostate cancer	0.000235	0.00054	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Prednisone—prostate cancer	0.000235	0.000539	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Epirubicin—prostate cancer	0.000234	0.000538	CcSEcCtD
Hydroxychloroquine—Alopecia—Capecitabine—prostate cancer	0.000233	0.000535	CcSEcCtD
Hydroxychloroquine—Mood swings—Doxorubicin—prostate cancer	0.000233	0.000535	CcSEcCtD
Hydroxychloroquine—Ataxia—Doxorubicin—prostate cancer	0.000231	0.000531	CcSEcCtD
Hydroxychloroquine—Mental disorder—Capecitabine—prostate cancer	0.000231	0.000531	CcSEcCtD
Hydroxychloroquine—Malnutrition—Capecitabine—prostate cancer	0.00023	0.000527	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000229	0.000526	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Etoposide—prostate cancer	0.000228	0.000524	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Epirubicin—prostate cancer	0.000227	0.000522	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Doxorubicin—prostate cancer	0.000227	0.000521	CcSEcCtD
Hydroxychloroquine—Skin disorder—Etoposide—prostate cancer	0.000226	0.000519	CcSEcCtD
Hydroxychloroquine—Nausea—Goserelin—prostate cancer	0.000225	0.000517	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Doxorubicin—prostate cancer	0.000225	0.000515	CcSEcCtD
Hydroxychloroquine—Nausea—Conjugated Estrogens—prostate cancer	0.000223	0.000512	CcSEcCtD
Hydroxychloroquine—Urticaria—Mitoxantrone—prostate cancer	0.000223	0.000511	CcSEcCtD
Hydroxychloroquine—Anorexia—Etoposide—prostate cancer	0.000222	0.00051	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Estradiol—prostate cancer	0.000222	0.000508	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Mitoxantrone—prostate cancer	0.000221	0.000508	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Mitoxantrone—prostate cancer	0.000221	0.000508	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000221	0.000508	CcSEcCtD
Hydroxychloroquine—Eye disorder—Prednisone—prostate cancer	0.00022	0.000504	CcSEcCtD
Hydroxychloroquine—Anaemia—Docetaxel—prostate cancer	0.000219	0.000503	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Epirubicin—prostate cancer	0.000218	0.000501	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Doxorubicin—prostate cancer	0.000217	0.000498	CcSEcCtD
Hydroxychloroquine—Vision blurred—Capecitabine—prostate cancer	0.000217	0.000497	CcSEcCtD
Hydroxychloroquine—Asthenia—Estradiol—prostate cancer	0.000216	0.000495	CcSEcCtD
Hydroxychloroquine—Pruritus—Estradiol—prostate cancer	0.000213	0.000488	CcSEcCtD
Hydroxychloroquine—Leukopenia—Docetaxel—prostate cancer	0.000212	0.000487	CcSEcCtD
Hydroxychloroquine—Anaemia—Capecitabine—prostate cancer	0.000212	0.000487	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Doxorubicin—prostate cancer	0.00021	0.000483	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Epirubicin—prostate cancer	0.00021	0.000481	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Docetaxel—prostate cancer	0.000209	0.000479	CcSEcCtD
Hydroxychloroquine—Weight decreased—Epirubicin—prostate cancer	0.000208	0.000477	CcSEcCtD
Hydroxychloroquine—Alopecia—Prednisone—prostate cancer	0.000208	0.000477	CcSEcCtD
Hydroxychloroquine—Somnolence—Etoposide—prostate cancer	0.000207	0.000475	CcSEcCtD
Hydroxychloroquine—Vertigo—Capecitabine—prostate cancer	0.000206	0.000474	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000206	0.000474	CcSEcCtD
Hydroxychloroquine—Mental disorder—Prednisone—prostate cancer	0.000206	0.000473	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Estradiol—prostate cancer	0.000206	0.000472	CcSEcCtD
Hydroxychloroquine—Leukopenia—Capecitabine—prostate cancer	0.000206	0.000472	CcSEcCtD
Hydroxychloroquine—Convulsion—Docetaxel—prostate cancer	0.000206	0.000472	CcSEcCtD
Hydroxychloroquine—Drowsiness—Epirubicin—prostate cancer	0.000205	0.00047	CcSEcCtD
Hydroxychloroquine—Malnutrition—Prednisone—prostate cancer	0.000205	0.00047	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000203	0.000466	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Etoposide—prostate cancer	0.000203	0.000465	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Capecitabine—prostate cancer	0.000202	0.000463	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Doxorubicin—prostate cancer	0.000202	0.000463	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Etoposide—prostate cancer	0.000201	0.000462	CcSEcCtD
Hydroxychloroquine—Asthenia—Mitoxantrone—prostate cancer	0.000201	0.000461	CcSEcCtD
Hydroxychloroquine—Fatigue—Etoposide—prostate cancer	0.000201	0.000461	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000201	0.00046	CcSEcCtD
Hydroxychloroquine—Pain—Etoposide—prostate cancer	0.000199	0.000457	CcSEcCtD
Hydroxychloroquine—Dizziness—Estradiol—prostate cancer	0.000199	0.000456	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000194	0.000446	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000194	0.000445	CcSEcCtD
Hydroxychloroquine—Oedema—Docetaxel—prostate cancer	0.000194	0.000444	CcSEcCtD
Hydroxychloroquine—Vision blurred—Prednisone—prostate cancer	0.000193	0.000443	CcSEcCtD
Hydroxychloroquine—Weight decreased—Doxorubicin—prostate cancer	0.000192	0.000441	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Mitoxantrone—prostate cancer	0.000192	0.00044	CcSEcCtD
Hydroxychloroquine—Vomiting—Estradiol—prostate cancer	0.000191	0.000439	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Epirubicin—prostate cancer	0.000191	0.000439	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Etoposide—prostate cancer	0.000191	0.000437	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Docetaxel—prostate cancer	0.00019	0.000436	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Docetaxel—prostate cancer	0.00019	0.000435	CcSEcCtD
Hydroxychloroquine—Rash—Estradiol—prostate cancer	0.00019	0.000435	CcSEcCtD
Hydroxychloroquine—Drowsiness—Doxorubicin—prostate cancer	0.00019	0.000435	CcSEcCtD
Hydroxychloroquine—Dermatitis—Estradiol—prostate cancer	0.000189	0.000435	CcSEcCtD
Hydroxychloroquine—Anaemia—Prednisone—prostate cancer	0.000189	0.000434	CcSEcCtD
Hydroxychloroquine—Headache—Estradiol—prostate cancer	0.000188	0.000432	CcSEcCtD
Hydroxychloroquine—Skin disorder—Docetaxel—prostate cancer	0.000188	0.000432	CcSEcCtD
Hydroxychloroquine—Agitation—Prednisone—prostate cancer	0.000188	0.000432	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000188	0.000431	CcSEcCtD
Hydroxychloroquine—Oedema—Capecitabine—prostate cancer	0.000187	0.00043	CcSEcCtD
Hydroxychloroquine—Angioedema—Prednisone—prostate cancer	0.000187	0.000429	CcSEcCtD
Hydroxychloroquine—Urticaria—Etoposide—prostate cancer	0.000185	0.000425	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Epirubicin—prostate cancer	0.000185	0.000424	CcSEcCtD
Hydroxychloroquine—Anorexia—Docetaxel—prostate cancer	0.000185	0.000424	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Etoposide—prostate cancer	0.000184	0.000423	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Etoposide—prostate cancer	0.000184	0.000423	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Capecitabine—prostate cancer	0.000184	0.000422	CcSEcCtD
Hydroxychloroquine—Vertigo—Prednisone—prostate cancer	0.000184	0.000422	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Epirubicin—prostate cancer	0.000184	0.000422	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Capecitabine—prostate cancer	0.000184	0.000421	CcSEcCtD
Hydroxychloroquine—Skin disorder—Capecitabine—prostate cancer	0.000182	0.000418	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Prednisone—prostate cancer	0.00018	0.000413	CcSEcCtD
Hydroxychloroquine—Anorexia—Capecitabine—prostate cancer	0.000179	0.00041	CcSEcCtD
Hydroxychloroquine—Nausea—Estradiol—prostate cancer	0.000179	0.00041	CcSEcCtD
Hydroxychloroquine—Vomiting—Mitoxantrone—prostate cancer	0.000178	0.000409	CcSEcCtD
Hydroxychloroquine—Convulsion—Prednisone—prostate cancer	0.000177	0.000407	CcSEcCtD
Hydroxychloroquine—Visual impairment—Epirubicin—prostate cancer	0.000177	0.000407	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Doxorubicin—prostate cancer	0.000177	0.000406	CcSEcCtD
Hydroxychloroquine—Rash—Mitoxantrone—prostate cancer	0.000177	0.000405	CcSEcCtD
Hydroxychloroquine—Dermatitis—Mitoxantrone—prostate cancer	0.000176	0.000405	CcSEcCtD
Hydroxychloroquine—Headache—Mitoxantrone—prostate cancer	0.000176	0.000403	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Epirubicin—prostate cancer	0.000174	0.000399	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000173	0.000397	CcSEcCtD
Hydroxychloroquine—Somnolence—Docetaxel—prostate cancer	0.000172	0.000395	CcSEcCtD
Hydroxychloroquine—Eye disorder—Epirubicin—prostate cancer	0.000172	0.000394	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Etoposide—prostate cancer	0.000172	0.000394	CcSEcCtD
Hydroxychloroquine—Tinnitus—Epirubicin—prostate cancer	0.000171	0.000393	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Doxorubicin—prostate cancer	0.000171	0.000392	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Doxorubicin—prostate cancer	0.00017	0.00039	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Docetaxel—prostate cancer	0.000168	0.000386	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000167	0.000384	CcSEcCtD
Hydroxychloroquine—Asthenia—Etoposide—prostate cancer	0.000167	0.000384	CcSEcCtD
Hydroxychloroquine—Oedema—Prednisone—prostate cancer	0.000167	0.000383	CcSEcCtD
Hydroxychloroquine—Fatigue—Docetaxel—prostate cancer	0.000167	0.000383	CcSEcCtD
Hydroxychloroquine—Nausea—Mitoxantrone—prostate cancer	0.000166	0.000382	CcSEcCtD
Hydroxychloroquine—Pain—Docetaxel—prostate cancer	0.000166	0.00038	CcSEcCtD
Hydroxychloroquine—Pruritus—Etoposide—prostate cancer	0.000165	0.000378	CcSEcCtD
Hydroxychloroquine—Visual impairment—Doxorubicin—prostate cancer	0.000164	0.000376	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Prednisone—prostate cancer	0.000164	0.000376	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Capecitabine—prostate cancer	0.000163	0.000374	CcSEcCtD
Hydroxychloroquine—Alopecia—Epirubicin—prostate cancer	0.000162	0.000373	CcSEcCtD
Hydroxychloroquine—Skin disorder—Prednisone—prostate cancer	0.000162	0.000372	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000162	0.000371	CcSEcCtD
Hydroxychloroquine—Fatigue—Capecitabine—prostate cancer	0.000162	0.000371	CcSEcCtD
Hydroxychloroquine—Mental disorder—Epirubicin—prostate cancer	0.000161	0.00037	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Doxorubicin—prostate cancer	0.000161	0.000369	CcSEcCtD
Hydroxychloroquine—Pain—Capecitabine—prostate cancer	0.00016	0.000368	CcSEcCtD
Hydroxychloroquine—Malnutrition—Epirubicin—prostate cancer	0.00016	0.000367	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Etoposide—prostate cancer	0.000159	0.000366	CcSEcCtD
Hydroxychloroquine—Anorexia—Prednisone—prostate cancer	0.000159	0.000365	CcSEcCtD
Hydroxychloroquine—Eye disorder—Doxorubicin—prostate cancer	0.000159	0.000365	CcSEcCtD
Hydroxychloroquine—Tinnitus—Doxorubicin—prostate cancer	0.000159	0.000364	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Docetaxel—prostate cancer	0.000158	0.000363	CcSEcCtD
Hydroxychloroquine—Tension—Epirubicin—prostate cancer	0.000157	0.00036	CcSEcCtD
Hydroxychloroquine—Nervousness—Epirubicin—prostate cancer	0.000155	0.000357	CcSEcCtD
Hydroxychloroquine—Dizziness—Etoposide—prostate cancer	0.000154	0.000354	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Capecitabine—prostate cancer	0.000153	0.000352	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Docetaxel—prostate cancer	0.000153	0.000351	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Docetaxel—prostate cancer	0.000153	0.000351	CcSEcCtD
Hydroxychloroquine—Vision blurred—Epirubicin—prostate cancer	0.000151	0.000346	CcSEcCtD
Hydroxychloroquine—Alopecia—Doxorubicin—prostate cancer	0.00015	0.000345	CcSEcCtD
Hydroxychloroquine—Mental disorder—Doxorubicin—prostate cancer	0.000149	0.000342	CcSEcCtD
Hydroxychloroquine—Urticaria—Capecitabine—prostate cancer	0.000149	0.000342	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Capecitabine—prostate cancer	0.000148	0.00034	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Capecitabine—prostate cancer	0.000148	0.00034	CcSEcCtD
Hydroxychloroquine—Vomiting—Etoposide—prostate cancer	0.000148	0.00034	CcSEcCtD
Hydroxychloroquine—Malnutrition—Doxorubicin—prostate cancer	0.000148	0.00034	CcSEcCtD
Hydroxychloroquine—Anaemia—Epirubicin—prostate cancer	0.000148	0.000339	CcSEcCtD
Hydroxychloroquine—Agitation—Epirubicin—prostate cancer	0.000147	0.000338	CcSEcCtD
Hydroxychloroquine—Rash—Etoposide—prostate cancer	0.000147	0.000337	CcSEcCtD
Hydroxychloroquine—Dermatitis—Etoposide—prostate cancer	0.000147	0.000337	CcSEcCtD
Hydroxychloroquine—Headache—Etoposide—prostate cancer	0.000146	0.000335	CcSEcCtD
Hydroxychloroquine—Tension—Doxorubicin—prostate cancer	0.000145	0.000333	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Prednisone—prostate cancer	0.000145	0.000333	CcSEcCtD
Hydroxychloroquine—Fatigue—Prednisone—prostate cancer	0.000144	0.00033	CcSEcCtD
Hydroxychloroquine—Nervousness—Doxorubicin—prostate cancer	0.000144	0.00033	CcSEcCtD
Hydroxychloroquine—Vertigo—Epirubicin—prostate cancer	0.000144	0.00033	CcSEcCtD
Hydroxychloroquine—Leukopenia—Epirubicin—prostate cancer	0.000143	0.000329	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Docetaxel—prostate cancer	0.000143	0.000327	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Epirubicin—prostate cancer	0.000141	0.000323	CcSEcCtD
Hydroxychloroquine—Vision blurred—Doxorubicin—prostate cancer	0.00014	0.00032	CcSEcCtD
Hydroxychloroquine—Asthenia—Docetaxel—prostate cancer	0.000139	0.000319	CcSEcCtD
Hydroxychloroquine—Convulsion—Epirubicin—prostate cancer	0.000139	0.000318	CcSEcCtD
Hydroxychloroquine—Nausea—Etoposide—prostate cancer	0.000138	0.000318	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Capecitabine—prostate cancer	0.000138	0.000317	CcSEcCtD
Hydroxychloroquine—Pruritus—Docetaxel—prostate cancer	0.000137	0.000314	CcSEcCtD
Hydroxychloroquine—Anaemia—Doxorubicin—prostate cancer	0.000137	0.000314	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Prednisone—prostate cancer	0.000137	0.000313	CcSEcCtD
Hydroxychloroquine—Agitation—Doxorubicin—prostate cancer	0.000136	0.000312	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000135	0.000311	CcSEcCtD
Hydroxychloroquine—Asthenia—Capecitabine—prostate cancer	0.000135	0.000309	CcSEcCtD
Hydroxychloroquine—Vertigo—Doxorubicin—prostate cancer	0.000133	0.000305	CcSEcCtD
Hydroxychloroquine—Urticaria—Prednisone—prostate cancer	0.000133	0.000304	CcSEcCtD
Hydroxychloroquine—Pruritus—Capecitabine—prostate cancer	0.000133	0.000304	CcSEcCtD
Hydroxychloroquine—Leukopenia—Doxorubicin—prostate cancer	0.000133	0.000304	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Docetaxel—prostate cancer	0.000133	0.000304	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Prednisone—prostate cancer	0.000132	0.000303	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Prednisone—prostate cancer	0.000132	0.000303	CcSEcCtD
Hydroxychloroquine—Oedema—Epirubicin—prostate cancer	0.000131	0.0003	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Doxorubicin—prostate cancer	0.00013	0.000299	CcSEcCtD
Hydroxychloroquine—Convulsion—Doxorubicin—prostate cancer	0.000128	0.000294	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Capecitabine—prostate cancer	0.000128	0.000294	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Epirubicin—prostate cancer	0.000128	0.000294	CcSEcCtD
Hydroxychloroquine—Dizziness—Docetaxel—prostate cancer	0.000128	0.000294	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Epirubicin—prostate cancer	0.000128	0.000293	CcSEcCtD
Hydroxychloroquine—Skin disorder—Epirubicin—prostate cancer	0.000127	0.000291	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000125	0.000287	CcSEcCtD
Hydroxychloroquine—Anorexia—Epirubicin—prostate cancer	0.000125	0.000286	CcSEcCtD
Hydroxychloroquine—Dizziness—Capecitabine—prostate cancer	0.000124	0.000285	CcSEcCtD
Hydroxychloroquine—Vomiting—Docetaxel—prostate cancer	0.000123	0.000283	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Prednisone—prostate cancer	0.000123	0.000282	CcSEcCtD
Hydroxychloroquine—Rash—Docetaxel—prostate cancer	0.000122	0.00028	CcSEcCtD
Hydroxychloroquine—Dermatitis—Docetaxel—prostate cancer	0.000122	0.00028	CcSEcCtD
Hydroxychloroquine—Headache—Docetaxel—prostate cancer	0.000121	0.000278	CcSEcCtD
Hydroxychloroquine—Oedema—Doxorubicin—prostate cancer	0.000121	0.000277	CcSEcCtD
Hydroxychloroquine—Asthenia—Prednisone—prostate cancer	0.00012	0.000275	CcSEcCtD
Hydroxychloroquine—Vomiting—Capecitabine—prostate cancer	0.000119	0.000274	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Doxorubicin—prostate cancer	0.000119	0.000272	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Doxorubicin—prostate cancer	0.000118	0.000272	CcSEcCtD
Hydroxychloroquine—Rash—Capecitabine—prostate cancer	0.000118	0.000271	CcSEcCtD
Hydroxychloroquine—Pruritus—Prednisone—prostate cancer	0.000118	0.000271	CcSEcCtD
Hydroxychloroquine—Dermatitis—Capecitabine—prostate cancer	0.000118	0.000271	CcSEcCtD
Hydroxychloroquine—Headache—Capecitabine—prostate cancer	0.000117	0.00027	CcSEcCtD
Hydroxychloroquine—Skin disorder—Doxorubicin—prostate cancer	0.000117	0.000269	CcSEcCtD
Hydroxychloroquine—Somnolence—Epirubicin—prostate cancer	0.000116	0.000266	CcSEcCtD
Hydroxychloroquine—Anorexia—Doxorubicin—prostate cancer	0.000115	0.000264	CcSEcCtD
Hydroxychloroquine—Nausea—Docetaxel—prostate cancer	0.000115	0.000264	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Prednisone—prostate cancer	0.000114	0.000262	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Epirubicin—prostate cancer	0.000114	0.000261	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000113	0.000259	CcSEcCtD
Hydroxychloroquine—Fatigue—Epirubicin—prostate cancer	0.000113	0.000258	CcSEcCtD
Hydroxychloroquine—Pain—Epirubicin—prostate cancer	0.000112	0.000256	CcSEcCtD
Hydroxychloroquine—Nausea—Capecitabine—prostate cancer	0.000111	0.000256	CcSEcCtD
Hydroxychloroquine—Dizziness—Prednisone—prostate cancer	0.00011	0.000253	CcSEcCtD
Hydroxychloroquine—Somnolence—Doxorubicin—prostate cancer	0.000107	0.000247	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Epirubicin—prostate cancer	0.000107	0.000245	CcSEcCtD
Hydroxychloroquine—Vomiting—Prednisone—prostate cancer	0.000106	0.000244	CcSEcCtD
Hydroxychloroquine—Rash—Prednisone—prostate cancer	0.000105	0.000242	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisone—prostate cancer	0.000105	0.000241	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Doxorubicin—prostate cancer	0.000105	0.000241	CcSEcCtD
Hydroxychloroquine—Headache—Prednisone—prostate cancer	0.000105	0.00024	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000104	0.000239	CcSEcCtD
Hydroxychloroquine—Fatigue—Doxorubicin—prostate cancer	0.000104	0.000239	CcSEcCtD
Hydroxychloroquine—Urticaria—Epirubicin—prostate cancer	0.000104	0.000238	CcSEcCtD
Hydroxychloroquine—Pain—Doxorubicin—prostate cancer	0.000103	0.000237	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Epirubicin—prostate cancer	0.000103	0.000237	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Epirubicin—prostate cancer	0.000103	0.000237	CcSEcCtD
Hydroxychloroquine—Nausea—Prednisone—prostate cancer	9.92e-05	0.000228	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Doxorubicin—prostate cancer	9.88e-05	0.000227	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Epirubicin—prostate cancer	9.62e-05	0.000221	CcSEcCtD
Hydroxychloroquine—Urticaria—Doxorubicin—prostate cancer	9.6e-05	0.00022	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Doxorubicin—prostate cancer	9.55e-05	0.000219	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Doxorubicin—prostate cancer	9.55e-05	0.000219	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CALCA—prostate cancer	9.46e-05	0.000305	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CREBBP—prostate cancer	9.43e-05	0.000305	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—EGFR—prostate cancer	9.4e-05	0.000304	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CTNNB1—prostate cancer	9.38e-05	0.000303	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Epirubicin—prostate cancer	9.37e-05	0.000215	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP3A4—prostate cancer	9.37e-05	0.000303	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDH1—prostate cancer	9.36e-05	0.000302	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Epirubicin—prostate cancer	9.24e-05	0.000212	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP3A4—prostate cancer	9.24e-05	0.000298	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL12—prostate cancer	9.24e-05	0.000298	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP1B1—prostate cancer	9.21e-05	0.000298	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CDKN1A—prostate cancer	9.16e-05	0.000296	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BCL2L1—prostate cancer	9.16e-05	0.000296	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PTEN—prostate cancer	9.14e-05	0.000295	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP1B1—prostate cancer	9.09e-05	0.000293	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MAP2K1—prostate cancer	9e-05	0.000291	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CD—prostate cancer	8.94e-05	0.000289	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Epirubicin—prostate cancer	8.94e-05	0.000205	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—GGT1—prostate cancer	8.92e-05	0.000288	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Doxorubicin—prostate cancer	8.9e-05	0.000204	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—KRAS—prostate cancer	8.88e-05	0.000287	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—NCOA1—prostate cancer	8.79e-05	0.000284	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TLR4—prostate cancer	8.73e-05	0.000282	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—EP300—prostate cancer	8.72e-05	0.000282	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CASP9—prostate cancer	8.7e-05	0.000281	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Doxorubicin—prostate cancer	8.67e-05	0.000199	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP19A1—prostate cancer	8.66e-05	0.00028	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Epirubicin—prostate cancer	8.64e-05	0.000198	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—FGF2—prostate cancer	8.56e-05	0.000277	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Doxorubicin—prostate cancer	8.55e-05	0.000196	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP19A1—prostate cancer	8.54e-05	0.000276	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—SRC—prostate cancer	8.48e-05	0.000274	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PRKCQ—prostate cancer	8.43e-05	0.000272	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NGFR—prostate cancer	8.43e-05	0.000272	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ICAM1—prostate cancer	8.37e-05	0.00027	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—RXRA—prostate cancer	8.36e-05	0.00027	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAP3K7—prostate cancer	8.33e-05	0.000269	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Epirubicin—prostate cancer	8.31e-05	0.000191	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—BAD—prostate cancer	8.3e-05	0.000268	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Doxorubicin—prostate cancer	8.27e-05	0.00019	CcSEcCtD
Hydroxychloroquine—Rash—Epirubicin—prostate cancer	8.24e-05	0.000189	CcSEcCtD
Hydroxychloroquine—Dermatitis—Epirubicin—prostate cancer	8.23e-05	0.000189	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—JAK2—prostate cancer	8.21e-05	0.000265	CbGpPWpGaD
Hydroxychloroquine—Headache—Epirubicin—prostate cancer	8.18e-05	0.000188	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CA—prostate cancer	8.16e-05	0.000263	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—BCL2—prostate cancer	8.13e-05	0.000263	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—COMT—prostate cancer	8.05e-05	0.00026	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTP1—prostate cancer	8.01e-05	0.000259	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—MDM2—prostate cancer	8.01e-05	0.000259	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGF10—prostate cancer	8.01e-05	0.000259	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Doxorubicin—prostate cancer	7.99e-05	0.000183	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—EGF—prostate cancer	7.95e-05	0.000257	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IRS1—prostate cancer	7.95e-05	0.000257	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—COMT—prostate cancer	7.94e-05	0.000256	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ADRB2—prostate cancer	7.93e-05	0.000256	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTP1—prostate cancer	7.9e-05	0.000255	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ERBB2—prostate cancer	7.9e-05	0.000255	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CB—prostate cancer	7.79e-05	0.000252	CbGpPWpGaD
Hydroxychloroquine—Nausea—Epirubicin—prostate cancer	7.76e-05	0.000178	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—VAV3—prostate cancer	7.73e-05	0.00025	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—GSK3B—prostate cancer	7.72e-05	0.000249	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Doxorubicin—prostate cancer	7.68e-05	0.000176	CcSEcCtD
Hydroxychloroquine—Rash—Doxorubicin—prostate cancer	7.62e-05	0.000175	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFBR2—prostate cancer	7.62e-05	0.000246	CbGpPWpGaD
Hydroxychloroquine—Dermatitis—Doxorubicin—prostate cancer	7.61e-05	0.000175	CcSEcCtD
Hydroxychloroquine—Headache—Doxorubicin—prostate cancer	7.57e-05	0.000174	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—ITPR1—prostate cancer	7.5e-05	0.000242	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CREBBP—prostate cancer	7.45e-05	0.000241	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—EGFR—prostate cancer	7.43e-05	0.00024	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDH1—prostate cancer	7.4e-05	0.000239	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTM1—prostate cancer	7.36e-05	0.000238	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDKN1B—prostate cancer	7.31e-05	0.000236	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTM1—prostate cancer	7.26e-05	0.000235	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IL6—prostate cancer	7.22e-05	0.000233	CbGpPWpGaD
Hydroxychloroquine—Nausea—Doxorubicin—prostate cancer	7.18e-05	0.000165	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF1R—prostate cancer	7.17e-05	0.000231	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL2—prostate cancer	7.16e-05	0.000231	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MAP2K1—prostate cancer	7.11e-05	0.00023	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CD—prostate cancer	7.07e-05	0.000228	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—KRAS—prostate cancer	7.02e-05	0.000227	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP1A1—prostate cancer	6.98e-05	0.000225	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CTNNB1—prostate cancer	6.91e-05	0.000223	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HAO1—prostate cancer	6.89e-05	0.000223	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP1A1—prostate cancer	6.89e-05	0.000222	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LPL—prostate cancer	6.87e-05	0.000222	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PDGFRB—prostate cancer	6.81e-05	0.00022	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—FGF2—prostate cancer	6.77e-05	0.000219	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDKN1A—prostate cancer	6.75e-05	0.000218	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PTEN—prostate cancer	6.73e-05	0.000218	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—AKT1—prostate cancer	6.66e-05	0.000215	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ITGB3—prostate cancer	6.64e-05	0.000214	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—JAK2—prostate cancer	6.49e-05	0.00021	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CA—prostate cancer	6.45e-05	0.000208	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ERBB3—prostate cancer	6.44e-05	0.000208	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGFR2—prostate cancer	6.43e-05	0.000208	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BCL2—prostate cancer	6.43e-05	0.000208	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EP300—prostate cancer	6.42e-05	0.000207	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—MDM2—prostate cancer	6.33e-05	0.000205	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—SRC—prostate cancer	6.25e-05	0.000202	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ERBB2—prostate cancer	6.24e-05	0.000202	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TERT—prostate cancer	6.17e-05	0.000199	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CB—prostate cancer	6.16e-05	0.000199	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—STAT3—prostate cancer	6.02e-05	0.000195	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HIF1A—prostate cancer	5.9e-05	0.000191	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDKN1B—prostate cancer	5.78e-05	0.000187	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LEP—prostate cancer	5.76e-05	0.000186	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IL6—prostate cancer	5.71e-05	0.000184	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CAV1—prostate cancer	5.71e-05	0.000184	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL2—prostate cancer	5.66e-05	0.000183	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KDR—prostate cancer	5.64e-05	0.000182	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ADI1—prostate cancer	5.62e-05	0.000181	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PSAT1—prostate cancer	5.62e-05	0.000181	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CSAD—prostate cancer	5.62e-05	0.000181	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GRHL1—prostate cancer	5.62e-05	0.000181	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CBR1—prostate cancer	5.62e-05	0.000181	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TST—prostate cancer	5.62e-05	0.000181	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ESR1—prostate cancer	5.5e-05	0.000178	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EGFR—prostate cancer	5.47e-05	0.000177	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CTNNB1—prostate cancer	5.46e-05	0.000176	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—BAD—prostate cancer	5.37e-05	0.000173	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDKN1A—prostate cancer	5.34e-05	0.000172	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTEN—prostate cancer	5.32e-05	0.000172	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AKT1—prostate cancer	5.27e-05	0.00017	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CKMT2—prostate cancer	5.22e-05	0.000169	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—UGT2B17—prostate cancer	5.22e-05	0.000169	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GRHPR—prostate cancer	5.22e-05	0.000169	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—UGT2B15—prostate cancer	5.22e-05	0.000169	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CG—prostate cancer	5.2e-05	0.000168	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—APC—prostate cancer	5.2e-05	0.000168	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KRAS—prostate cancer	5.17e-05	0.000167	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGF—prostate cancer	5.14e-05	0.000166	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IRS1—prostate cancer	5.14e-05	0.000166	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EP300—prostate cancer	5.08e-05	0.000164	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GSK3B—prostate cancer	4.99e-05	0.000161	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—SRC—prostate cancer	4.94e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—INS—prostate cancer	4.92e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NAGLU—prostate cancer	4.91e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—RFK—prostate cancer	4.91e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SULT2B1—prostate cancer	4.91e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PGAM2—prostate cancer	4.91e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTM3—prostate cancer	4.91e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MBTPS1—prostate cancer	4.91e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AOX1—prostate cancer	4.91e-05	0.000159	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CREBBP—prostate cancer	4.82e-05	0.000156	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—STAT3—prostate cancer	4.76e-05	0.000154	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF1—prostate cancer	4.76e-05	0.000154	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CA—prostate cancer	4.75e-05	0.000153	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP3A43—prostate cancer	4.65e-05	0.00015	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AMACR—prostate cancer	4.65e-05	0.00015	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—DEGS1—prostate cancer	4.65e-05	0.00015	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SRD5A2—prostate cancer	4.65e-05	0.00015	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NAT1—prostate cancer	4.65e-05	0.00015	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MAP2K1—prostate cancer	4.6e-05	0.000149	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CD—prostate cancer	4.57e-05	0.000148	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SERPINE1—prostate cancer	4.52e-05	0.000146	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HSD17B1—prostate cancer	4.44e-05	0.000143	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGF2—prostate cancer	4.38e-05	0.000141	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EGFR—prostate cancer	4.33e-05	0.00014	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOS3—prostate cancer	4.32e-05	0.000139	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6—prostate cancer	4.21e-05	0.000136	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—JAK2—prostate cancer	4.19e-05	0.000135	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MDM2—prostate cancer	4.09e-05	0.000132	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KRAS—prostate cancer	4.09e-05	0.000132	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ERBB2—prostate cancer	4.04e-05	0.00013	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CB—prostate cancer	3.98e-05	0.000129	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—B4GALT4—prostate cancer	3.96e-05	0.000128	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HPGD—prostate cancer	3.96e-05	0.000128	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AKT1—prostate cancer	3.88e-05	0.000125	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL8—prostate cancer	3.83e-05	0.000124	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CA—prostate cancer	3.76e-05	0.000121	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1B—prostate cancer	3.74e-05	0.000121	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TNFRSF21—prostate cancer	3.72e-05	0.00012	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CASP3—prostate cancer	3.66e-05	0.000118	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL2—prostate cancer	3.66e-05	0.000118	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTAP—prostate cancer	3.62e-05	0.000117	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP7B1—prostate cancer	3.62e-05	0.000117	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCND1—prostate cancer	3.57e-05	0.000115	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CTNNB1—prostate cancer	3.53e-05	0.000114	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SULT1E1—prostate cancer	3.53e-05	0.000114	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SRD5A1—prostate cancer	3.53e-05	0.000114	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP9—prostate cancer	3.46e-05	0.000112	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1A—prostate cancer	3.45e-05	0.000111	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTEN—prostate cancer	3.44e-05	0.000111	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HSD17B3—prostate cancer	3.36e-05	0.000109	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ACSL4—prostate cancer	3.36e-05	0.000109	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6—prostate cancer	3.33e-05	0.000107	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EP300—prostate cancer	3.28e-05	0.000106	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PHGDH—prostate cancer	3.23e-05	0.000104	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ARG2—prostate cancer	3.23e-05	0.000104	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—UMPS—prostate cancer	3.23e-05	0.000104	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SRC—prostate cancer	3.19e-05	0.000103	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LDHB—prostate cancer	3.16e-05	0.000102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—prostate cancer	3.11e-05	0.0001	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP3A5—prostate cancer	3.11e-05	0.0001	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT3—prostate cancer	3.08e-05	9.94e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT1—prostate cancer	3.07e-05	9.91e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PDHA1—prostate cancer	3e-05	9.69e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—UCP3—prostate cancer	3e-05	9.69e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TCN2—prostate cancer	3e-05	9.69e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTA3—prostate cancer	3e-05	9.69e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC22A3—prostate cancer	2.86e-05	9.24e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HSD3B1—prostate cancer	2.86e-05	9.24e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—prostate cancer	2.86e-05	9.24e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFB1—prostate cancer	2.85e-05	9.22e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGFR—prostate cancer	2.8e-05	9.04e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTA4—prostate cancer	2.74e-05	8.86e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TBXAS1—prostate cancer	2.74e-05	8.86e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTA2—prostate cancer	2.67e-05	8.63e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KRAS—prostate cancer	2.64e-05	8.54e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SULT1A1—prostate cancer	2.64e-05	8.53e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCG5—prostate cancer	2.64e-05	8.53e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTA1—prostate cancer	2.58e-05	8.33e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTO1—prostate cancer	2.55e-05	8.24e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NAT2—prostate cancer	2.55e-05	8.24e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HSD3B2—prostate cancer	2.55e-05	8.24e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PLCB2—prostate cancer	2.44e-05	7.9e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LRP2—prostate cancer	2.44e-05	7.9e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP2C18—prostate cancer	2.44e-05	7.9e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CA—prostate cancer	2.43e-05	7.84e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—P4HB—prostate cancer	2.4e-05	7.74e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—prostate cancer	2.35e-05	7.59e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC22A1—prostate cancer	2.33e-05	7.53e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SULT2A1—prostate cancer	2.27e-05	7.34e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MED12—prostate cancer	2.24e-05	7.22e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GNG5—prostate cancer	2.22e-05	7.17e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6—prostate cancer	2.15e-05	6.94e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NCOA3—prostate cancer	2.14e-05	6.9e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HPGDS—prostate cancer	2.04e-05	6.58e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP2C19—prostate cancer	2.03e-05	6.54e-05	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT1—prostate cancer	1.98e-05	6.41e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ACHE—prostate cancer	1.98e-05	6.39e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTT1—prostate cancer	1.98e-05	6.39e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP2A6—prostate cancer	1.95e-05	6.31e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKR1C3—prostate cancer	1.9e-05	6.14e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PRKACB—prostate cancer	1.89e-05	6.11e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP17A1—prostate cancer	1.87e-05	6.05e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NCOA2—prostate cancer	1.78e-05	5.76e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC5A5—prostate cancer	1.7e-05	5.5e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP2E1—prostate cancer	1.66e-05	5.37e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NQO1—prostate cancer	1.64e-05	5.31e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TH—prostate cancer	1.62e-05	5.23e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.6e-05	5.18e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.58e-05	5.09e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GGT1—prostate cancer	1.53e-05	4.93e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NCOA1—prostate cancer	1.5e-05	4.85e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.48e-05	4.78e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—RXRA—prostate cancer	1.43e-05	4.62e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—COMT—prostate cancer	1.38e-05	4.45e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTP1—prostate cancer	1.37e-05	4.43e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ITPR1—prostate cancer	1.35e-05	4.36e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TYMS—prostate cancer	1.27e-05	4.12e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTM1—prostate cancer	1.26e-05	4.07e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LPL—prostate cancer	1.24e-05	3.99e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.19e-05	3.86e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.18e-05	3.82e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.11e-05	3.6e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPARA—prostate cancer	1.09e-05	3.53e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CAV1—prostate cancer	1.03e-05	3.32e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CG—prostate cancer	9.35e-06	3.02e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—INS—prostate cancer	8.85e-06	2.86e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CREBBP—prostate cancer	8.67e-06	2.8e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CD—prostate cancer	8.22e-06	2.66e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NOS3—prostate cancer	7.76e-06	2.51e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CB—prostate cancer	7.17e-06	2.31e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS2—prostate cancer	7.1e-06	2.29e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTEN—prostate cancer	6.19e-06	2e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—EP300—prostate cancer	5.9e-06	1.91e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CA—prostate cancer	4.37e-06	1.41e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKT1—prostate cancer	3.57e-06	1.15e-05	CbGpPWpGaD
